ToolGen Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:ToolGen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011849
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ToolGen Inc (ToolGen) is a genome editing company that concentrates on translating the genetic knowledge into transformative products for biomedicine and agriculture. The company creates intellectual property rights for essential tools and technologies for editing the genetic information in plant, microbial, animal, and human cells. It offers CRISPR/ CAS9 services; engineering services and reporter services. ToolGen offers RNA-guided endonucleases, an engineered nuclease based on a bacterial CRISPR/Cas9 system that provides novel tools for the genome editing. The company has presence in China, South Korea and the US. ToolGen is headquartered in Seoul, South Korea.

ToolGen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ToolGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ToolGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ToolGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ToolGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
ToolGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ToolGen Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Green Cross Cell and ToolGen to Enter into Partnership 10
Licensing Agreements 11
Thermo Fisher Enters into Licensing Agreement with ToolGen for CRISPR/Cas9 11
Life Technologies Enters Into Licensing Agreement With ToolGen For TAL Effector Technology 12
ToolGen Inc – Key Competitors 13
ToolGen Inc – Key Employees 14
ToolGen Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
ToolGen Inc, Pharmaceuticals & Healthcare, Key Facts 2
ToolGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ToolGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ToolGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ToolGen Inc, Deals By Therapy Area, 2011 to YTD 2017 8
ToolGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Green Cross Cell and ToolGen to Enter into Partnership 10
Thermo Fisher Enters into Licensing Agreement with ToolGen for CRISPR/Cas9 11
Life Technologies Enters Into Licensing Agreement With ToolGen For TAL Effector Technology 12
ToolGen Inc, Key Competitors 13
ToolGen Inc, Key Employees 14

★海外企業調査レポート[ToolGen Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GCL-Poly Energy Holdings Ltd (3800)-エネルギー分野:企業M&A・提携分析
    Summary GCL-Poly Energy Holdings Ltd. (GCL) is a provider of solar photovoltaic (PV) material and professional PV system solutions. The company produces and supplies high-quality solar grade and semiconductor grade polysilicon raw materials and silicon wafers to companies operating in the solar indu …
  • Selventa Inc-製薬・医療分野:企業M&A・提携分析
    Summary Selventa Inc (Selventa), formerly Genstruct Inc is a healthcare technology services provider that operates life science consulting projects. The company offers system diagnostic development services that identifies molecular mechanisms, networks and biomarkers to develop therapeutics, molecu …
  • Fresenius Kabi USA LLC-製薬・医療分野:企業M&A・提携分析
    Summary Fresenius Kabi USA LLC (Fresenius Kabi), a subsidiary of Fresenius Kabi AG, is a pharmaceutical and medical device company which provides lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. It provides products and services to critically and chronically il …
  • Otto Bock HealthCare GmbH-医療機器分野:企業M&A・提携分析
    Summary Otto Bock HealthCare GmbH (Otto Bock), a group company of Otto Bock Holding GmbH & Co. KG, is a medical device company that manufactures and distributes prosthetic and orthotic devices. It also offers mobility and seating solutions for the physically disabled adults and children. The product …
  • Sermsuk Public Company Limited:企業の戦略・SWOT・財務分析
    SummarySermsuk Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • Creekside Springs, LLC:企業の戦略・SWOT・財務分析
    SummaryCreekside Springs, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • United Continental Holdings Inc:戦略・SWOT・企業財務分析
    United Continental Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary United Continental Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Accelerate Diagnostics Inc (AXDX):企業のM&A・提携動向(医療機器分野)
    Summary Accelerate Diagnostics Inc (Accelerate), formerly Accelr8 Technology Corporation is an in vitro diagnostics company. It undertakes the development and commercialization of instrumentation for identification and testing the antibiotic susceptibility of infectious pathogens. The company harnes …
  • Ariens Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ariens Company Mergers and Acqu …
  • Diageo plc:企業の戦略・SWOT・財務分析
    Diageo plc - Strategy, SWOT and Corporate Finance Report Summary Diageo plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Wilbur-Ellis Company:企業の戦略・SWOT・財務分析
    Wilbur-Ellis Company - Strategy, SWOT and Corporate Finance Report Summary Wilbur-Ellis Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AdnaGen AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' AdnaGen AG Mergers and Acquisit …
  • PBF Energy Inc. (PBF)-石油・ガス分野:企業M&A・提携分析
    Summary PBF Energy Inc. (PBF Energy) is an independent oil refining company. It owns and operates crude oil refineries and related facilities in the US. Its refining assets include Delaware City refinery, Delaware; Paulsboro refinery, New Jersey; Chalmette refinery, Louisiana, Torrance, California a …
  • Dean Foods Co:戦略・SWOT・企業財務分析
    Dean Foods Co - Strategy, SWOT and Corporate Finance Report Summary Dean Foods Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • National Real Estate Company K.S.C.:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "National Real Estate Company K.S.C." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetri …
  • INPEX Holdings, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' INPEX Holdings, Inc. Mergers an …
  • Fortistar, LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Fortistar, LLC Mergers and Acqu …
  • Jardine Strategic Holdings Limited (J37):企業の財務及び戦略的SWOT分析
    Summary Jardine Strategic Holdings Limited (Jardine Strategic) a subsidiary of Jardine Matheson Holdings Limited is a diversified company that offers trading services. Its businesses comprise a combination of cash generating activities and long-term property assets. Jardine Strategic provides servic …
  • Plantronics, Inc. (PLT):企業の財務・戦略的SWOT分析
    Plantronics, Inc. (PLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Grasim Industries Limited:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Grasim Industries Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Inte …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆